Lobbying: all issues, rounded to the nearest $10,000. Two filers, same 21 months. This PAC gives money raised from the company’s employees; the company itself can’t give to campaigns from its treasury.
Spend by quarter Pro
Free account See ProWhat they lobby on
MethodPTC Therapeutics reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), with its own in-house lobbyists and 2 outside firms. What follows is what the filings say it lobbied on, not which way.
Issue areas ranked by quarters filedQ4 24 → Q3 26
- Health Issues8/8
- Medical/Disease Research/Clinical Labs8/8
- Medicare/Medicaid8/8
- Taxation/Internal Revenue Code8/8
- Trade (domestic/foreign)3/8
Bills named in the filings 15 bills, this period
- H.R. 1262 Mikaela Naylon Give Kids a Chance Act11 filings
- S. 932 Give Kids a Chance Act of 202511 filings
- H.R. 1414 Cameron’s Law7 filings
- H.R. 1492 To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.7 filings
- H.R. 1990 American Innovation and R&D Competitiveness Act of 20257 filings
10 more, 8 named in only one filing · Show all 15
- H.R. 946 ORPHAN Cures Act7 filings
- S. 822 / H.R. 1532 Scientific EXPERT Act of 20252 filings
- H.R. 1350, 118th Cameron’s Law1 filing
- H.R. 2666, 118th Medicaid VBPs for Patients Act1 filing
- H.R. 5539, 118th ORPHAN Cures Act1 filing
- H.R. 7174, 118th To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.1 filing
- H.R. 7384, 118th Creating Hope Reauthorization Act of 20241 filing
- H.R. 2673, 118th American Innovation and R&D Competitiveness Act of 2023 Broad bill1 filing
- H.R. 7024, 118th Tax Relief for American Families and Workers Act of 2024 Broad bill1 filing
- S. 866, 118th American Innovation and Jobs Act Broad bill1 filing
From the filings
“Issues related to Section 174 R&D Amortization, including H.R. 1990 - American Innovation and R&D Competitiveness Act of 2025 Issues related to the Orphan Drug Tax Credit, including H.R. 1414 - Camerons Law”
“Awareness of Aromatic L-amino acid decarboxylase deficiency (AADCD) Improving diagnostic testing for rare pediatric genetic diseases Awareness of Huntingtons Disease Awareness of Friedreichs Ataxia Awareness of Phenylketonuria Awareness of Duchenne Muscular Dystrophy”
Contacted as listed on the filings
- U.S. House
- U.S. Senate
- EOP
- HHS
- DOC
- CMS
The House and Senate appear in every quarter; agencies in 4 of 8.
Every filing since 2015 Pro
Free account See ProSource: Lobbying Disclosure Act filings (LD-2) by PTC Therapeutics, Senate Office of Public Records. Filings are due 20 days after each quarter ends.
From FEC filings: direct gifts this PAC reported, net of refunds · How we count
Gave directly to 38 sitting members of Congress in 2025–26.
See every candidate and member PTC Therapeutics gave to directly, how much, and how its money splits between the parties.
This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.
Create a free account See what Pro adds Log in